Citation Impact 2023
Journal Impact Factor: 4.4
5-year Journal Impact Factor: 4.9
Source Normalized Impact per Paper (SNIP): 1.294
SCImago Journal Rank (SJR): 1.518
Speed 2024
Submission to first editorial decision (median days): 11
Submission to acceptance (median days): 118
Usage 2024
Downloads: 3,978,337
Altmetric mentions: 1,452
Volume 9 Supplement 2
Advances in systemic sclerosis and related fibrotic and vascular conditions
Reviews
Edited by Carol M Black, Christopher P Denton, Steffen Gay, Lars C Huber and James R Seibold
This supplement has been supported by an educational grant from Actelion Pharmaceuticals Ltd
-
Citation: Arthritis Research & Therapy 2007 9(Suppl 2):S1
-
How does endothelial cell injury start? The role of endothelin in systemic sclerosis
A considerable amount of research time has been invested in studies aimed at elucidating pathogenic processes in systemic sclerosis (SSc). Despite this, major challenges for biomedical science remain, such as ...
Citation: Arthritis Research & Therapy 2007 9(Suppl 2):S2 -
Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis
Angiogenesis is important in the pathogenesis of systemic inflammatory rheumatic diseases, a family of related disorders that includes rheumatoid arthritis and systemic sclerosis. Rheumatoid arthritis is the r...
Citation: Arthritis Research & Therapy 2007 9(Suppl 2):S3 -
Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions
Fibrosis, characterized by excessive extracellular matrix accumulation, is a common feature of many connective tissue diseases, notably scleroderma (systemic sclerosis). Experimental studies suggest that a com...
Citation: Arthritis Research & Therapy 2007 9(Suppl 2):S4 -
Genetic factors in systemic sclerosis
A number of genetic loci have been identified that appear to be associated with systemic sclerosis (SSc; scleroderma). There is mounting evidence suggesting that these genetic associations may in fact be assoc...
Citation: Arthritis Research & Therapy 2007 9(Suppl 2):S5 -
Therapeutic targets in systemic sclerosis
The precise aetiology of systemic sclerosis (SSc) remains elusive, but significant advances over the past few years have improved our understanding of the underlying pathogenic processes and identified key pat...
Citation: Arthritis Research & Therapy 2007 9(Suppl 2):S6 -
Clinical trials in systemic sclerosis: lessons learned and outcomes
The pathogenesis of systemic sclerosis (SSc) is complex and largely unclear. The clinical heterogeneity of the disease and its progression over a number of years makes the choice of endpoints in the design of ...
Citation: Arthritis Research & Therapy 2007 9(Suppl 2):S7 -
Pulmonary hypertension associated with sarcoidosis
Pulmonary involvement is common in sarcoidosis, an immune-mediated inflammatory disorder that is characterized by non-caseating granulomas in tissue. Sarcoid patients with advanced pulmonary disease, especiall...
Citation: Arthritis Research & Therapy 2007 9(Suppl 2):S8 -
Vasculitis: mechanisms involved and clinical manifestations
Systemic vasculitis, an inflammatory necrotizing disease of the blood vessel walls, can occur secondary to autoimmune diseases, including connective tissue diseases. Various pathogenic mechanisms have been imp...
Citation: Arthritis Research & Therapy 2007 9(Suppl 2):S9 -
Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue disease
Despite advances in elucidating the pathogenic factors responsible for its development, systemic sclerosis remains complex and poorly understood, and treatment options are limited. Multidisciplinary collaborat...
Citation: Arthritis Research & Therapy 2007 9(Suppl 2):S10